Merck KGaA (FRA:MRK)
124.90
-0.90 (-0.72%)
At close: Jan 30, 2026
Merck KGaA Employees
Merck KGaA had 62,346 employees as of September 30, 2025. The number of employees increased by 91 or 0.15% compared to the same quarter last year.
Employees
62,346
Change
91
Growth
0.15%
Revenue / Employee
€341,177
Profits / Employee
€47,413
Market Cap
54.59B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2025 | 62,346 | 91 | 0.15% | 62,346 | 0 |
| Jun 30, 2025 | 63,160 | 984 | 1.58% | 63,160 | 0 |
| Mar 31, 2025 | 62,604 | 259 | 0.42% | 62,604 | 0 |
| Dec 31, 2024 | 59,020 | -3,888 | -6.18% | 59,020 | 0 |
| Sep 30, 2024 | 62,255 | -1,042 | -1.65% | 62,255 | 0 |
| Jun 30, 2024 | 62,176 | -1,536 | -2.41% | 62,176 | 0 |
| Mar 31, 2024 | 62,345 | -1,666 | -2.60% | 62,345 | 0 |
| Dec 31, 2023 | 62,908 | -1,324 | -2.06% | 62,908 | 0 |
| Sep 30, 2023 | 63,297 | -426 | -0.67% | 63,297 | 0 |
| Jun 30, 2023 | 63,712 | 942 | 1.50% | 63,712 | 0 |
| Mar 31, 2023 | 64,011 | 2,503 | 4.07% | 64,011 | 0 |
| Dec 31, 2022 | 64,232 | 3,898 | 6.46% | 64,232 | 0 |
| Sep 30, 2022 | 63,723 | 4,415 | 7.44% | 63,723 | 0 |
| Jun 30, 2022 | 62,770 | 4,362 | 7.47% | 62,770 | 0 |
| Mar 31, 2022 | 61,508 | 3,658 | 6.32% | 61,508 | 0 |
| Dec 31, 2021 | 60,334 | 2,207 | 3.80% | 60,334 | 0 |
| Sep 30, 2021 | 59,308 | 1,231 | 2.12% | 59,308 | 0 |
| Jun 30, 2021 | 58,408 | 885 | 1.54% | 58,408 | 0 |
| Mar 31, 2021 | 57,850 | 399 | 0.69% | 57,850 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Paul Hartmann AG | 10,082 |
| Mainova AG | 3,416 |
| Gelsenwasser AG | 1,898 |
| Maschinenfabrik Berthold Hermle AG | 1,603 |
| EUROKAI GmbH & Co. KGaA | 950 |
| tonies SE | 567 |
| Lechwerke AG | 459 |
| Northern Data AG | 199 |
Merck KGaA News
- 5 days ago - EQS-AFR: Merck KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements - Wallstreet:Online
- 5 days ago - EQS-AFR: Merck KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - Wallstreet:Online
- 11 days ago - EQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 16 days ago - Merck KGaA (MKKGY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - Seeking Alpha
- 18 days ago - Merck KGaA (MKKGY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 19 days ago - FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor - Benzinga
- 23 days ago - MilliporeSigma: Curiosity Cub Completes 2025 Tour, Inspiring Future Innovators Through AI - Finanz Nachrichten
- 5 weeks ago - Merck KGaA: Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor - Finanz Nachrichten